Lymphoproliferative disorders in heart transplant recipients: role of hepatitis C virus (HCV) and Epstein-Barr virus (EBV) infection
- 1 June 2000
- journal article
- Published by Frontiers Media SA in Transplant International
- Vol. 13 (S1) , S402-S405
- https://doi.org/10.1111/j.1432-2277.2000.tb02070.x
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- High prevalence of hepatitis C virus infection in patients with B‐cell lymphoproliferative disorders in ItalyAmerican Journal of Hematology, 1997
- Extrahepatic Manifestations of Hepatitis CDigestive Diseases, 1996
- De novo solid malignancies after cardiac transplantationThe Annals of Thoracic Surgery, 1995
- Hepatitis C: A Multifaceted Disease: Review of Extrahepatic ManifestationsAnnals of Internal Medicine, 1995
- Clonal B‐cell expansions in peripheral blood of HCV‐infected patientsBritish Journal of Haematology, 1995
- Hepatitis C virus infection in patients with non‐Hodgkin's lymphomaBritish Journal of Haematology, 1994
- A Role for Hepatitis C Virus Infection in Type II CryoglobulinemiaNew England Journal of Medicine, 1992
- An Immunocytochemical Technique Offering Increased Sensitivity and Lowered Cost with a Streptavidin-Horseradish Peroxidase ConjugateJournal of Histotechnology, 1989
- INCREASED FREQUENCY OF POSTTRANSPLANT LYMPHOMAS IN PATIENTS TREATED WITH CYCLOSPORINE, AZATHIOPRINE, AND PREDNISONETransplantation, 1989
- THE FREQUENCY OF EPSTEIN-BARR VIRUS INFECTION AND ASSOCIATED LYMPHOPROLIFERATIVE SYNDROME AFTER TRANSPLANTATION AND ITS MANIFESTATIONS IN CHILDRENTransplantation, 1988